- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
UPDATED Apr 28, 2024
Companies which may present a buying opportunity after a dip in share price.
95 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
DCPH | US$25.28 | 73.4% | 74.7% | US$1.2b | US$24.13 | PS12.7x | E43.2% | n/a | ||
RCKT | US$21.98 | -7.9% | 20.0% | US$2.0b | US$50.31 | PB4x | E54.1% | n/a | ||
CVAC | US$2.33 | -7.9% | -66.7% | US$521.9m | US$10.30 | PS9x | E38.8% | n/a | ||
AGEN | US$12.76 | 121.1% | -57.7% | US$245.4m | US$88.75 | PS1.7x | E9.1% | n/a | ||
PTPI | US$0.70 | 8.3% | -83.7% | US$4.4m | US$4.00 | PB0.4x | E38.3% | n/a | ||
RGNX | US$16.05 | 2.6% | -20.1% | US$794.0m | US$39.83 | PS8.7x | E35.5% | n/a | ||
ALLO | US$2.84 | -16.5% | -48.6% | US$493.4m | US$11.66 | PS5103.7x | E9.1% | n/a | ||
SAGE | US$13.69 | 6.2% | -71.9% | US$823.9m | US$22.22 | PS9x | E43.6% | n/a | ||
SGMO | US$0.52 | 2.4% | -65.4% | US$107.4m | US$3.50 | PB1.3x | E49.6% | n/a | ||
IMVT | US$27.49 | -4.3% | 56.0% | US$3.9b | US$50.43 | PB5.9x | E46.7% | n/a | ||
KRON | US$1.00 | 4.2% | -38.7% | US$60.1m | US$4.25 | PS9.6x | E7.5% | n/a | ||
SNCE | US$5.75 | 0.3% | 30.9% | US$34.7m | US$13.83 | PB0.7x | E66.7% | n/a | ||
ADPT | US$2.75 | 9.6% | -62.6% | US$383.2m | US$6.67 | PS2.4x | E22.8% | n/a | ||
TRDA | US$12.45 | -5.0% | -2.4% | US$403.5m | US$21.00 | PS3.1x | E-1.5% | n/a | ||
SIGA | US$8.79 | 5.3% | 51.0% | US$625.2m | n/a | PE9.2x | S8.8% | 6.8% | ||
PROC | US$2.73 | 0.6% | -41.0% | US$307.7m | US$4.75 | PE5.9x | E-6.1% | n/a | ||
IMCR | US$58.10 | 4.1% | -0.4% | US$3.0b | US$83.96 | PS11.8x | E25.8% | n/a | ||
AKYA | US$3.86 | -1.0% | -44.8% | US$187.6m | US$9.00 | PS2x | E55.3% | n/a | ||
CSBR | US$4.92 | -2.8% | 1.2% | US$68.2m | US$6.00 | PS1.4x | S10.8% | n/a | ||
DNLI | US$15.60 | -2.4% | -39.5% | US$2.2b | US$40.27 | PS6.7x | E8.1% | n/a | ||
MRSN | US$3.16 | 0.3% | -32.9% | US$359.7m | US$6.50 | PS10.5x | E19.9% | n/a | ||
TXG | US$28.40 | 2.2% | -45.8% | US$3.3b | US$51.29 | PS5.5x | E56.5% | n/a | ||
TARA | US$2.93 | -4.1% | -3.1% | US$60.2m | US$27.80 | PB0.9x | E-0.4% | n/a | ||
AMLX | US$1.90 | -4.0% | -93.3% | US$119.7m | US$4.25 | PE2.6x | E-18.7% | n/a |